Shockwave Medical Inc (SWAV) Return on Equity ROE from the first quarter 2024 to first quarter 2023 and annually, average high and low, overall ranking from Mar 31 2024 to Mar 31 2023 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Shockwave Medical Inc   (NASDAQ: SWAV)

Shockwave Medical Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Shockwave Medical Inc in the first quarter 2024?
Shockwave Medical Inc achieved a return on average equity (ROE) of 24.79 % in its first quarter 2024, this is above SWAV's average return on equity of 3.42%.
Shockwave Medical Inc shareholder's equity over the 12 months ending in its first quarter 2024 are valued at $660 million

ROE has advanced compared to 23.97% in the fourth quarter 2023, due to net income growth.

Within the Medical Equipment & Supplies industry 10 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the fourth quarter 2023 from 319 to 453.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter
Y / Y Equity Change 31.73 % 30.78 % 68.92 % 102.22 % -
Y / Y Net Income Change 41.46 % -68.56 % -0.05 % 12.91 % 169.44 %
Net Income (TTM) in Millions 163 147 244 244 241
Return On Equity (TTM) 24.79 % 23.97 % 42.41 % 47.48 % 55.22 %
SWAV's Total Ranking # 453 # 319 # 216 # 168 # 105
Equity (TTM) in Millions 752 669 601 617 571
Seq. Equity Change 12.42 % 11.22 % -2.54 % 8.1 % 11.61 %
Seq. Net Income Change 24.92 % 26.64 % 21.22 % -26.23 % -72.23 %

Back to SWAV Management Effectiveness >> SWAV's 5 Years Annual ROE >> Compare SWAV ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 11
Sector # 56
Overall # 453

Return On Equity Statistics
High Average Low
59.99 %
3.42 %
-38.18 %
(Dec 31 2022)   (Mar 31 2020)





SWAV Annual Return On Equity (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019
Total Equity in Millions 669 511 242 226 193
Y / Y Equity Change 30.78 % 111.44 % 7.17 % 17.13 % -
Net Income in Millions 147 216 -9 -66 -51
Y / Y Net Income Change -31.81 % - - - -
Return On Equity 22.03 % 42.24 % -3.78 % -29.11 % -26.53 %

Back to SWAV Management Effectiveness >> SWAV's 5 Years Annual ROE >> Compare SWAV ROE to its Competitors




Annual Roe Comment
In 2023 ROE decreased compared to the previous year to 22.03 %, due to deterioration of net income.


More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
SWAV's' Return on Equity at Yahoo Finance
SWAV's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for SWAV's Competitors
Subscribers only: Roe for Shockwave Medical Inc 's Suppliers
Subscribers only: Return On Equity for SWAV's Customers




Companies with similar Return On Equity at Mar 31 2024, within Healthcare Sector ROE
Scienture Holdings Inc   66.82 %
Idexx Laboratories Inc  63.66 %
Waters Corporation  63.25 %
Enzo Biochem Inc  61.16 %
Lantheus Holdings Inc   61.14 %
Medpace Holdings Inc   59.74 %
Amgen Inc   58.59 %
Abbvie Inc   55.25 %
Nrc Health  54.83 %
Johnson and Johnson  53.73 %
Eli Lilly And Company  53.13 %
Siga Technologies Inc  51.97 %
Elite Pharmaceuticals Inc   49.73 %
Zoetis Inc   48.39 %
Lite Strategy Inc   48.32 %
Collegium Pharmaceutical Inc   46.81 %
Protagonist Therapeutics inc   43.42 %
Kewaunee Scientific Corporation  42.26 %
Earth Science Tech Inc   41.28 %
Puma Biotechnology Inc   35.43 %
Insulet Corporation  34.86 %
Baxter International Inc   34.85 %
Star Equity Holdings Inc   34.71 %
Alkermes Plc   34.12 %
Prestige Consumer Healthcare Inc   31.73 %
Alaunos Therapeutics Inc   31.61 %
Agilent Technologies inc   30.63 %
Bruker Corporation  30.39 %
Semler Scientific inc   30.36 %
Spero Therapeutics Inc   30.04 %

Date modified: 2026-09-08T15:11:15+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.